Interstitial Lung Disease and Diffuse Alveolar Hemorrhage, the Two Key Pulmonary Manifestations in Microscopic

Min Jung Kim1, Kichul Shin1

  • 1Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National Boramae Medical Center, Seoul, Republic of Korea.

Insights

Microscopic polyangiitis (MPA) can cause lung issues like interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH). ILD in MPA often mimics idiopathic pulmonary fibrosis on imaging.

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis affecting small vessels.
  • Pulmonary manifestations, including interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH), significantly increase MPA morbidity and mortality.
  • ILD is particularly prevalent in MPA, often linked to myeloperoxidase-ANCA and presenting as pulmonary fibrosis with a usual interstitial pneumonia pattern.

Purpose of the Study:

  • To review the pathogenesis, clinical, radiographic, and histopathologic features of ILD and DAH in MPA.
  • To summarize outcomes and therapeutic strategies for these pulmonary complications.

Main Methods:

  • Literature review focusing on MPA, ILD, and DAH.
  • Analysis of clinical, imaging, and histopathology data.
  • Synthesis of current understanding of disease mechanisms and treatment.

Main Results:

  • ILD in MPA is frequently associated with myeloperoxidase-ANCA.
  • Radiographic findings of ILD in MPA often resemble idiopathic pulmonary fibrosis, specifically the usual interstitial pneumonia pattern.
  • DAH and ILD represent critical pulmonary complications impacting MPA patient prognosis.

Conclusions:

  • Understanding the distinct features of ILD and DAH in MPA is crucial for diagnosis and management.
  • Early recognition and appropriate therapy for these pulmonary manifestations can improve patient outcomes.
  • MPA-associated ILD shares radiographic similarities with idiopathic pulmonary fibrosis, necessitating careful differential diagnosis.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
195
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
538
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
83
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
690